http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109406790-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-323 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-581 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58 |
| filingDate | 2018-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109406790-B |
| titleOfInvention | Application of coenzyme Q10 and/or PCSK9 as marker for detecting atherosclerosis in preparation of reagent or kit |
| abstract | The invention provides application of coenzyme Q10 and/or PCSK9 as a marker for detecting atherosclerosis in preparation of a reagent or a kit. Coenzyme Q10 and/or PCSK910 are used as diagnosis and/or detection markers, and the sensitivity is highest under the same specificity condition. When the CoQ10 and PCSK9 markers are combined with any other marker for joint detection, the sensitivity can also maintain the sensitivity level of the CoQ10 and PCSK9 joint detection method. The marker for detecting and/or diagnosing atherosclerosis provided by the application can be applied to preparation of a detection reagent or a kit for various diseases related to atherosclerosis, and has a wider market application prospect. |
| priorityDate | 2018-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 126.